NASDAQ:NARI Inari Medical (NARI) Stock Price, News & Analysis $45.52 +3.84 (+9.21%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$41.92▼$46.4550-Day Range$41.68▼$58.6252-Week Range$36.73▼$69.40Volume1.66 million shsAverage Volume1.02 million shsMarket Capitalization$2.65 billionP/E RatioN/ADividend YieldN/APrice Target$59.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Inari Medical alerts: Email Address Inari Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside30.7% Upside$59.50 Price TargetShort InterestHealthy6.59% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.79Based on 23 Articles This WeekInsider TradingSelling Shares$6.39 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.75) to $0.15 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.51 out of 5 starsMedical Sector249th out of 910 stocksSurgical & Medical Instruments Industry34th out of 95 stocks 4.3 Analyst's Opinion Consensus RatingInari Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 5 buy ratings, 5 hold ratings, and no sell ratings.Amount of Analyst CoverageInari Medical has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Inari Medical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted6.59% of the outstanding shares of Inari Medical have been sold short.Short Interest Ratio / Days to CoverInari Medical has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in Inari Medical has recently decreased by 16.38%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldInari Medical does not currently pay a dividend.Dividend GrowthInari Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NARI. Previous Next 2.7 News and Social Media Coverage News SentimentInari Medical has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 23 news articles for Inari Medical this week, compared to 9 articles on an average week.Search InterestOnly 3 people have searched for NARI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Inari Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inari Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,393,074.00 in company stock.Percentage Held by Insiders10.60% of the stock of Inari Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions90.98% of the stock of Inari Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inari Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Inari Medical are expected to grow in the coming year, from ($0.75) to $0.15 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inari Medical is -111.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inari Medical is -111.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInari Medical has a P/B Ratio of 6.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Inari Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Mode MobilePre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.Claim Exclusive 100% Bonus: $0.25/Share About Inari Medical Stock (NASDAQ:NARI)Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.Read More NARI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NARI Stock News HeadlinesAugust 15, 2024 | insidertrades.comInari Medical, Inc. (NASDAQ:NARI) CFO Sells $239,950.00 in StockSeptember 7 at 2:33 AM | americanbankingnews.comBrokerages Set Inari Medical, Inc. (NASDAQ:NARI) PT at $59.50September 7, 2024 | Paradigm Press (Ad)Kamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… September 6 at 7:38 AM | markets.businessinsider.comInari Medical: A Strong Buy on Robust Product Reception and Promising Financial OutlookSeptember 6 at 2:19 AM | americanbankingnews.comInari Medical, Inc. Forecasted to Earn FY2024 Earnings of ($0.41) Per Share (NASDAQ:NARI)September 5 at 1:46 AM | americanbankingnews.comQ3 2024 Earnings Forecast for Inari Medical, Inc. Issued By Leerink Partnrs (NASDAQ:NARI)September 4 at 2:49 PM | msn.comLeerink Partners Initiates Coverage of Inari Medical (NARI) with Market Perform RecommendationSeptember 4 at 9:47 AM | markets.businessinsider.comInari Medical: Navigating Competitive Threats and Growth Potential in Venous Thromboembolism TreatmentSeptember 7, 2024 | Paradigm Press (Ad)Kamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… September 4 at 5:49 AM | americanbankingnews.comLeerink Partnrs Upgrades Inari Medical (NASDAQ:NARI) to HoldSeptember 4 at 3:05 AM | americanbankingnews.comInari Medical (NASDAQ:NARI) Coverage Initiated at Leerink PartnersAugust 31, 2024 | americanbankingnews.comInari Medical, Inc. (NASDAQ:NARI) Short Interest Down 16.4% in AugustAugust 30, 2024 | investing.comInari Medical Inc (NARI)August 28, 2024 | americanbankingnews.comPiper Sandler Reiterates Neutral Rating for Inari Medical (NASDAQ:NARI)August 27, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Inari Medical (NARI) and PROCEPT BioRobotics (PRCT)August 27, 2024 | markets.businessinsider.comInari Medical’s Resilience and Market Potential Affirm Buy RatingAugust 27, 2024 | finance.yahoo.comFDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most SeriousAugust 24, 2024 | reuters.comUS FDA classifies recall of Inari's catheter devices as 'most serious'See More Headlines Receive NARI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today9/07/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:NARI CUSIPN/A CIK1531048 Webwww.inarimedical.com Phone877-923-4747FaxN/AEmployees1,300Year FoundedN/APrice Target and Rating Average Stock Price Target$59.50 High Stock Price Target$71.00 Low Stock Price Target$47.00 Potential Upside/Downside+30.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)($0.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,640,000.00 Net Margins-10.42% Pretax Margin-6.41% Return on Equity-7.51% Return on Assets-5.25% Debt Debt-to-Equity RatioN/A Current Ratio1.80 Quick Ratio1.45 Sales & Book Value Annual Sales$547.47 million Price / Sales4.83 Cash Flow$0.09 per share Price / Cash Flow490.28 Book Value$7.27 per share Price / Book6.26Miscellaneous Outstanding Shares58,138,000Free Float51,975,000Market Cap$2.65 billion OptionableOptionable Beta1.00 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Andrew J. Hykes (Age 51)CEO, President & Director Comp: $1.54MMr. Mitchell C. Hill (Age 65)Chief Financial Officer Comp: $864.63kDr. Thomas M. Tu M.D. (Age 51)Chief Medical Officer Comp: $865.63kMr. Paul A. Koehn (Age 61)Senior Vice President of Operations Mr. Kevin StrangeSenior Vice President of Finance, Accounting, Strategy & Business DevelopmentMr. John Hsu C.F.A.Vice President of Investor RelationsMs. Angela AhmadGeneral Counsel & SecretaryMr. Eric KhairySenior Vice President of MarketingMr. Tim BennerSenior VP of Sales & Senior VP of U.S. SalesMs. Tara DunnSenior VP & GM of LimFlowMore ExecutivesKey CompetitorsNuVasiveNASDAQ:NUVACantel MedicalNYSE:CMDICU MedicalNASDAQ:ICUIMerit Medical SystemsNASDAQ:MMSIPenumbraNYSE:PENView All CompetitorsInsiders & InstitutionsMaven Securities LTDBought 5,000 shares on 8/29/2024Ownership: 0.034%Clearbridge Investments LLCSold 6,175 shares on 8/27/2024Ownership: 0.419%Algert Global LLCBought 31,926 shares on 8/16/2024Ownership: 0.055%Susquehanna International Group LLPSold 19,100 shares on 8/16/2024Ownership: 0.000%Point72 Asia Singapore Pte. Ltd.Bought 2,159 shares on 8/15/2024Ownership: 0.004%View All Insider TransactionsView All Institutional Transactions NARI Stock Analysis - Frequently Asked Questions How have NARI shares performed this year? Inari Medical's stock was trading at $64.92 on January 1st, 2024. Since then, NARI stock has decreased by 29.9% and is now trading at $45.52. View the best growth stocks for 2024 here. How were Inari Medical's earnings last quarter? Inari Medical, Inc. (NASDAQ:NARI) released its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of $0.01 by $0.09. Inari Medical's revenue for the quarter was up 22.5% compared to the same quarter last year. When did Inari Medical IPO? Inari Medical (NARI) raised $110 million in an initial public offering on Friday, May 22nd 2020. The company issued 7,300,000 shares at a price of $14.00-$16.00 per share. BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers. Who are Inari Medical's major shareholders? Top institutional shareholders of Inari Medical include Point72 Asset Management L.P. (2.55%), Armistice Capital LLC (1.74%), American Century Companies Inc. (1.69%) and Fiera Capital Corp (1.00%). Insiders that own company stock include Donald B Milder, William Hoffman, Andrew Hykes, Thomas Tu and Mitch C Hill. View institutional ownership trends. How do I buy shares of Inari Medical? Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Inari Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO) and Johnson & Johnson (JNJ). This page (NASDAQ:NARI) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inari Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inari Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NARI Stock Alerts